Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026)

Bausch Health Companies (BHC) posted Non-Current Deferred Tax Liability of $211.0 million for Q2 2026, up 17.88% sequentially from $179.0 million in Q1 2026, and up 46.53% YoY from $144.0 million in Q2 2025.

Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

Bausch Health Companies has reported Non-Current Deferred Tax Liability for 17 years, with the latest figure at $211.0 million in Q2 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 46.53% year-over-year to $211.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $211.0 million (up 46.53% YoY) and the FY2025 annual result came in at $147.0 million, down 62.88% from the prior year.
  • Non-Current Deferred Tax Liability advanced to $211.0 million in Q2 2026 per BHC's latest filing, from $179.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $552.0 million in Q1 2022 and troughed at $134.0 million in Q1 2025.
  • A 5-year average of $266.3 million and a median of $208.0 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Deferred Tax Liability sank 62.88% in 2025, then jumped 46.53% in 2026.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $390.0 million in 2022, then dropped by 1.03% to $386.0 million in 2023, then increased by 2.59% to $396.0 million in 2024, then tumbled by 62.88% to $147.0 million in 2025, then jumped by 43.54% to $211.0 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $211.0 million, $179.0 million, and $147.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 211.00 Mn
Jun 30, 2026 211.00 Mn
Mar 31, 2026 179.00 Mn
Mar 31, 2026 179.00 Mn
Dec 31, 2025 147.00 Mn
Dec 31, 2025 147.00 Mn
Sep 30, 2025 145.00 Mn
Sep 30, 2025 145.00 Mn
Jun 30, 2025 144.00 Mn
Jun 30, 2025 144.00 Mn
Mar 31, 2025 134.00 Mn
Mar 31, 2025 134.00 Mn
Dec 31, 2024 128.00 Mn
Dec 31, 2024 128.00 Mn
Sep 30, 2024 169.00 Mn
Sep 30, 2024 169.00 Mn
Jun 30, 2024 170.00 Mn
Jun 30, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn